HALO logo
halo search icon
Aptose Biosciences Inc.
Aptose Biosciences Inc.
APS · TSE

Aptose Biosciences Inc.

CA$2.33

0.00 (0.00%)
20/05/2026 12:00:00 AM
All-CompaniesAll-ConsensusHALO All
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Aptose Biosciences Inc. Overview

APS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About APS

icon

Telephone

1.647.479.9828

icon

Address

Suite 5300, 66 Wellington Street West, TD Bank Tower, Toronto, ON M5K 1E6

Description

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.

APS Price Chart

Key Stats

Market Cap

CA$5.95M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.02 - 2.59

Trade Value (12mth)

US$1,728.00

1 week

0%

1 month

-2.1%

YTD

15.35%

1 year

-4.9%

All time high

330480.00

Key Fundamentals

EPS 3 yr Growth

-94.90%

EBITDA Margin

0.00%

Operating Cashflow

-$22m

Free Cash Flow Return

-673.90%

ROIC

-780.40%

Interest Coverage

-28.80

Quick Ratio

0.70

Other Data

Shares Outstanding (Fully Diluted)

3m

HALO Sector

Healthcare

Next Company Report Date

23-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

APS Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-227.42-36.38-10.41locklocklock
EPS (Fully Diluted)
$locklocklocklock-227.42-36.38-10.41locklocklock
Growth
%locklocklocklock-11.58471.4locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Aptose Biosciences Inc. (APS:TSE)?
Halo FAQ
The current share price of Aptose Biosciences Inc. (APS:TSE) is CAD$2.33.
What is the 52-week high share price for Aptose Biosciences Inc. (APS:TSE)?
Halo FAQ
The 52-week high share price for Aptose Biosciences Inc. (APS:TSE) is CAD$2.59.
What is the 52-week low share price for Aptose Biosciences Inc. (APS:TSE)?
Halo FAQ
The 52-week low share price for Aptose Biosciences Inc. (APS:TSE) is CAD$1.02.
What is the dividend yield for Aptose Biosciences Inc. (APS:TSE)?
Halo FAQ
Aptose Biosciences Inc. (APS:TSE) does not pay a dividend.
What was Aptose Biosciences Inc. (APS:TSE) last dividend payment?
Halo FAQ
Aptose Biosciences Inc. (APS:TSE) does not pay a dividend.
What is the franking level for Aptose Biosciences Inc. (APS:TSE)?
Halo FAQ
Aptose Biosciences Inc. (APS:TSE) has a franking level of 0.00%.
In which sector is Aptose Biosciences Inc. (APS:TSE) classified?
Halo FAQ
Aptose Biosciences Inc. (APS:TSE) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.